Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature

Expert Opinion on Pharmacotherapy
Ala I IaconiRajesh Balkrishnan

Abstract

Parkinson's disease (PD) affects nearly 1 million Americans with a mean onset age of 60 years. Its progressive, neurodegenerative nature, causing motor complications and affecting mood, has a considerable impact on a patient's health-related quality of life. Pharmacologic therapies are the most widely utilized treatment. The broad range of drugs for treating PD warrants an assessment of each medication's health-related outcomes, which includes consideration of clinical, economic and patient-centered outcomes. This review seeks to explore the outcomes associated with drugs frequently appearing in the literature of the past 5 years and to comment on the direction of pharmacologic research and management of PD pharmacotherapy in the future.

References

Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·O RascolF Stocchi
Jun 5, 2003·Parkinsonism & Related Disorders·D CoyleJ-F Baladi
Nov 26, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Prithiva NavanPeter G Bain
Jul 21, 2004·Archives of Neurology·Robert G HollowayUNKNOWN Parkinson Study Group
Apr 29, 2005·International Journal of Clinical Practice·E K TanM C Wong
Sep 13, 2005·Parkinsonism & Related Disorders·Francisco Pereira da Silva-JúniorVeralice Meireles Sales de Bruin
Oct 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katia NoyesAndrew W Dick
Oct 14, 2005·Journal of Neurology·Stanley Fahn, UNKNOWN Parkinson Study Group
Oct 18, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·A H V Schapira
Nov 4, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Alexandre Castro-CaldasUNKNOWN Parkinson-Control Study Group
Dec 13, 2005·PharmacoEconomics·Katia NoyesUNKNOWN Parkinson Study Group
Dec 22, 2005·Acta Neurologica Scandinavica·P OdinP Schüler
Jan 31, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Katia NoyesUNKNOWN Parkinson Study Group
Feb 2, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kevin M BiglanUNKNOWN Parkinson Study Group
Mar 17, 2006·Neurology·S PålhagenUNKNOWN Swedish Parkinson Study Group
Mar 18, 2006·Acta Neurologica Scandinavica·C VossiusJ P Larsen
Mar 30, 2006·The Annals of Pharmacotherapy·Joumana HudryJohn M Cochran
Jul 4, 2006·Journal of the Neurological Sciences·Matthias R LemkeHeinz Reichmann
Aug 31, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Anette Schrag, Pauline Banks
Sep 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Olivier RascolUNKNOWN 056 Study Group
Oct 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Olivier RascolUNKNOWN Parkinson REGAIN Study Group
Oct 13, 2006·Neurology·Ubaldo Bonuccelli, Paolo Del Dotto
Oct 18, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Alexei Korchounov, Gregory Bogomazov
Nov 10, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzHermann Russ
Jan 4, 2007·Neurology·Miho MurataUNKNOWN Japan Zonisamide on PD Study Group
Mar 16, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F GrandasUNKNOWN PRACTICOMT Study Group
Apr 4, 2007·Neurology·R PahwaUNKNOWN EASE-PD Adjunct Study Investigators
Apr 18, 2007·Neurology·Peter A LeWittUNKNOWN SP 650 Study Group
May 16, 2007·Archives of Neurology·Joseph JankovicBabak Boroojerdi
Aug 21, 2007·Lancet Neurology·Angelo Antonini, Werner Poewe

❮ Previous
Next ❯

Citations

Jan 28, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J Benito-LeónUNKNOWN Neurological Disorders in Central Spain Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Neurology
Alexis Elbaz, Frédéric Moisan
La Presse médicale
Stéphane Thobois, Emmanuel Broussolle
British Medical Bulletin
C A Davie
© 2021 Meta ULC. All rights reserved